Skip Navigation

Philips Respironics issued a recall for some CPAP and BiLevel PAP devices and mechanical ventilators. Learn more.

 

COVID-19: We are vaccinating patients ages 12+. Learn more:

Vaccines | Testing | Patient Care | Visitor Guidelines | Coronavirus | Self-Checker | Email Alerts

Clinical Trials

Your participation will allow you to have firsthand experience with developing new medical treatments that may be beneficial to other patients with shoulder injuries and degenerative conditions. Clinical trial information is excerpted from www.clinicaltrials.gov.

Open Trials

A Post-Market, Prospective, Multi-Center, Open-Label, Single Arm Clinical Evaluation of the Integra TitanTM Modular Shoulder System 2.5 for Primary Shoulder Joint Replacement (IRB00169712)

Objective: To evaluate 2-year implant survivorship in subjects who receive the TSS-2.5 when used for primary shoulder arthroplasty.
Principle InvestigatorUmasuthan Srikumaran, M.D., M.P.H., M.B.A.
Eligibility Criteria: Candidate for total shoulder arthroplasty
Contact: Sanjana Vattigunta (443-516-1550 or svattig1@jhmi.edu)
Learn more about this study.

Post-operative Pain Control Following Shoulder Surgery

Objective: Evaluate overall pain medication consumption following surgical treatment for shoulder pathology
Principle InvestigatorUmasuthan Srikumaran, M.D., M.P.H., M.B.A.
Eligibility Criteria: Opioid-naive adults age 18-90 years old planning to undergo surgical treatment for shoulder pathology with Dr. Uma Srikumaran
Contact: Sanjana Vattigunta (443-516-1550 or svattig1@jhmi.edu)

back to top button